Indeed, the receptor for N-formylated peptides (which is expressed by DCs) appears to be required for dying cancer cells to elicit a tumor-targeting immune response, but it does so by binding to another danger signal, i.e., annexin A1 (ANXA1)201. Here, ANXA1 is linked to neoplasm.